Filing
Spy
Filing
Spy
Home
About
GILD
Gilead Sciences, Inc.
Biopharmaceutical company
CUSIP: 375558103
Healthcare
US
4 holders
Ownership
Activity
Fundamentals
2020 Q3
22 of 52 quarters
Total Value
$518.05M
Total Shares
8.20M
Net Share Change
+77.2K
Activity
3 buying
Investor
Value
Shares
Weight
Change
Dodge & Cox Stock Fund
$497.23M
7.87M
0.8%
Unchanged
Dodge & Cox Stock Fund
$497.23M
7.87M shares
Unchanged
Matrix Asset Advisors
$17.44M
275.9K
3.4%
ADD
+23.7K
(+9.4%)
Matrix Asset Advisors
$17.44M
275.9K shares
ADD
+23.7K
(+9.4%)
Maverick Capital
$2.87M
45.4K
0.1%
NEW
Maverick Capital
$2.87M
45.4K shares
NEW
Pzena Investment Management
$512.0K
8.1K
0.0%
NEW
Pzena Investment Management
$512.0K
8.1K shares
NEW
GILD — Gilead Sciences, Inc. - FilingSpy